{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:13:00Z","timestamp":1790741580304,"version":"4.1.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10769-9","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T03:24:47Z","timestamp":1751340287000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Deciphering the role of ERK and PI3K\/Akt as crosstalk pathways between fibroblast-like synoviocytes and osteoclasts; novel therapeutic approach for rheumatoid arthritis"],"prefix":"10.1007","volume":"52","author":[{"given":"Seyede-Sara","family":"Hassani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed-Alireza","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalil Tavakol","family":"Afshari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Akhlaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmadreza","family":"Jamshidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"6","key":"10769_CR1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","volume":"16","author":"G Nygaard","year":"2020","unstructured":"Nygaard G, Firestein GS (2020) Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat Rev Rheumatol 16(6):316\u2013333","journal-title":"Nat Rev Rheumatol"},{"key":"10769_CR2","doi-asserted-by":"crossref","first-page":"998554","DOI":"10.3389\/fimmu.2022.998554","volume":"13","author":"N Iwamoto","year":"2022","unstructured":"Iwamoto N, Kawakami A (2022) The monocyte-to-osteoclast transition in rheumatoid arthritis: recent findings. Front Immunol 13:998554","journal-title":"Front Immunol"},{"issue":"1","key":"10769_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.12979","volume":"189","author":"C Wehmeyer","year":"2017","unstructured":"Wehmeyer C, Pap T, Buckley CD, Naylor AJ (2017) The role of stromal cells in inflammatory bone loss. Clin Experimental Immunol 189(1):1\u201311","journal-title":"Clin Experimental Immunol"},{"issue":"2","key":"10769_CR4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","volume":"46","author":"GS Firestein","year":"2017","unstructured":"Firestein GS, McInnes IB (2017) Immunopathogenesis of rheumatoid arthritis. Immunity 46(2):183\u2013196","journal-title":"Immunity"},{"issue":"7","key":"10769_CR5","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/art.40504","volume":"70","author":"J Falconer","year":"2018","unstructured":"Falconer J, Murphy AN, Young SP, Clark AR, Tiziani S, Guma M et al (2018) Synovial cell metabolism and chronic inflammation in rheumatoid arthritis. Arthritis Rheumatol 70(7):984\u2013999","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10769_CR6","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41419-022-05479-0","volume":"13","author":"D Liu","year":"2022","unstructured":"Liu D, Li R, Xu S, Shi M, Kuang Y, Wang J et al (2022) SMOC2 promotes aggressive behavior of fibroblast-like synoviocytes in rheumatoid arthritis through transcriptional and post-transcriptional regulating MYO1C. Cell Death Dis 13(12):1035","journal-title":"Cell Death Dis"},{"issue":"1","key":"10769_CR7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrrheum.2012.190","volume":"9","author":"N Bottini","year":"2013","unstructured":"Bottini N, Firestein GS (2013) Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol 9(1):24\u201333","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10769_CR8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/s101650170001","volume":"11","author":"S Tanaka","year":"2001","unstructured":"Tanaka S, Nakamura K, Oda H (2001) The osteoclast: a potential therapeutic target of bone and joint destruction in rheumatoid arthritis. Mod Rheumatol 11(3):177\u2013183","journal-title":"Mod Rheumatol"},{"issue":"10","key":"10769_CR9","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1002\/art.23943","volume":"58","author":"S Herman","year":"2008","unstructured":"Herman S, M\u00fcller RB, Kr\u00f6nke G, Zwerina J, Redlich K, Hueber AJ et al (2008) Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis. Arthritis Rheumatism: Official J Am Coll Rheumatol 58(10):3041\u20133050","journal-title":"Arthritis Rheumatism: Official J Am Coll Rheumatol"},{"key":"10769_CR10","doi-asserted-by":"crossref","first-page":"107392","DOI":"10.1016\/j.intimp.2021.107392","volume":"93","author":"Z Wu","year":"2021","unstructured":"Wu Z, Ma D, Yang H, Gao J, Zhang G, Xu K et al (2021) Fibroblast-like synoviocytes in rheumatoid arthritis: surface markers and phenotypes. Int Immunopharmacol 93:107392","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"10769_CR11","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/art.1780391103","volume":"39","author":"GS Firestein","year":"1996","unstructured":"Firestein GS (1996) Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? Arthr Rhuem 39(11):1781\u20131790","journal-title":"Arthr Rhuem"},{"issue":"1","key":"10769_CR12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok B, Firestein GS (2010) Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 233(1):233\u2013255","journal-title":"Immunol Rev"},{"issue":"4","key":"10769_CR13","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/wrr.12939","volume":"29","author":"A Maglaviceanu","year":"2021","unstructured":"Maglaviceanu A, Wu B, Kapoor M (2021) Fibroblast-like synoviocytes: role in synovial fibrosis associated with osteoarthritis. Wound Repair Regeneration 29(4):642\u2013649","journal-title":"Wound Repair Regeneration"},{"key":"10769_CR14","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3389\/fimmu.2019.01395","volume":"10","author":"H Yoshitomi","year":"2019","unstructured":"Yoshitomi H (2019) Regulation of immune responses and chronic inflammation by fibroblast-like synoviocytes. Front Immunol 10:1395","journal-title":"Front Immunol"},{"issue":"12","key":"10769_CR15","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/nm.2050","volume":"15","author":"S Lef\u00e8vre","year":"2009","unstructured":"Lef\u00e8vre S, Knedla A, Tennie C, Kampmann A, Wunrau C, Dinser R et al (2009) Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med 15(12):1414\u20131420","journal-title":"Nat Med"},{"issue":"1","key":"10769_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-017-1303-3","volume":"19","author":"MF Bustamante","year":"2017","unstructured":"Bustamante MF, Garcia-Carbonell R, Whisenant KD, Guma M (2017) Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis. Arthritis Res Therapy 19(1):1\u201312","journal-title":"Arthritis Res Therapy"},{"issue":"11","key":"10769_CR17","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/rheumatology\/41.11.1232","volume":"41","author":"T Hirayama","year":"2002","unstructured":"Hirayama T, Danks L, Sabokbar A, Athanasou N (2002) Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis. Rheumatology 41(11):1232\u20131239","journal-title":"Rheumatology"},{"issue":"6","key":"10769_CR18","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jbspin.2013.04.002","volume":"80","author":"B Le Goff","year":"2013","unstructured":"Le Goff B, Berthelot J-M, Maugars Y, Heymann D (2013) Osteoclasts in RA: diverse origins and functions. Joint Bone Spine 80(6):586\u2013591","journal-title":"Joint Bone Spine"},{"issue":"4","key":"10769_CR19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3390\/jcm8040431","volume":"8","author":"MJ Kim","year":"2019","unstructured":"Kim MJ, Kim WS, Byun J-E, Choi JH, Yoon SR, Choi I et al (2019) Inhibition of osteoclastogenesis by thioredoxin-interacting protein-derived peptide (TN13). J Clin Med 8(4):431","journal-title":"J Clin Med"},{"issue":"11","key":"10769_CR20","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/ard.55.11.816","volume":"55","author":"Y Fujikawa","year":"1996","unstructured":"Fujikawa Y, Sabokbar A, Neale S, Athanasou NA (1996) Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis. Ann Rheum Dis 55(11):816","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10769_CR21","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jos.2018.06.001","volume":"23","author":"S Tanaka","year":"2018","unstructured":"Tanaka S (2018) Emerging anti-osteoclast therapy for rheumatoid arthritis. J Orthop Sci 23(5):717\u2013721","journal-title":"J Orthop Sci"},{"issue":"2","key":"10769_CR22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/rheumatology\/kes259","volume":"52","author":"J Kikuta","year":"2013","unstructured":"Kikuta J, Ishii M (2013) Osteoclast migration, differentiation and function: novel therapeutic targets for rheumatic diseases. Rheumatology 52(2):226\u2013234","journal-title":"Rheumatology"},{"key":"10769_CR23","doi-asserted-by":"crossref","first-page":"1034050","DOI":"10.3389\/fimmu.2022.1034050","volume":"13","author":"Q Niu","year":"2022","unstructured":"Niu Q, Gao J, Wang L, Liu J, Zhang L (2022) Regulation of differentiation and generation of osteoclasts in rheumatoid arthritis. Front Immunol 13:1034050","journal-title":"Front Immunol"},{"key":"10769_CR24","first-page":"1","volume":"9","author":"G Schett","year":"2007","unstructured":"Schett G (2007) Cells of the synovium in rheumatoid arthritis. Osteoclasts Arthritis Res Therapy 9:1\u20136","journal-title":"Osteoclasts Arthritis Res Therapy"},{"key":"10769_CR25","doi-asserted-by":"crossref","unstructured":"Yokota K (2023) Osteoclast differentiation in rheumatoid arthritis. Immunological Med.:1\u20136","DOI":"10.1080\/25785826.2023.2220931"},{"key":"10769_CR26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.intimp.2018.10.016","volume":"65","author":"AK Rana","year":"2018","unstructured":"Rana AK, Li Y, Dang Q, Yang F (2018) Monocytes in rheumatoid arthritis: Circulating precursors of macrophages and osteoclasts and, their heterogeneity and plasticity role in RA pathogenesis. Int Immunopharmacol 65:348\u2013359","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"10769_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar2046","volume":"8","author":"Y Komano","year":"2006","unstructured":"Komano Y, Nanki T, Hayashida K, Taniguchi K, Miyasaka N (2006) Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts. Arthritis Res Therapy 8(5):1\u201314","journal-title":"Arthritis Res Therapy"},{"issue":"1","key":"10769_CR28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.imlet.2007.03.004","volume":"110","author":"K-W Kim","year":"2007","unstructured":"Kim K-W, Cho M-L, Lee S-H, Oh H-J, Kang C-M, Ju JH et al (2007) Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation. Immunol Lett 110(1):54\u201364","journal-title":"Immunol Lett"},{"issue":"12","key":"10769_CR29","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","volume":"203","author":"K Sato","year":"2006","unstructured":"Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y et al (2006) Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203(12):2673\u20132682","journal-title":"J Exp Med"},{"issue":"7","key":"10769_CR30","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3109\/08820139.2013.822766","volume":"42","author":"PP Souza","year":"2013","unstructured":"Souza PP, Lerner UH (2013) The role of cytokines in inflammatory bone loss. Immunol Investig 42(7):555\u2013622","journal-title":"Immunol Investig"},{"issue":"5","key":"10769_CR31","first-page":"6605","volume":"17","author":"G Luo","year":"2018","unstructured":"Luo G, Li F, Li X, Wang ZG, Zhang B (2018) TNF\u2013\u03b1 and RANKL promote osteoclastogenesis by upregulating RANK via the NF\u2013\u03baB pathway. Mol Med Rep 17(5):6605\u20136611","journal-title":"Mol Med Rep"},{"issue":"3","key":"10769_CR32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cyto.2004.02.001","volume":"26","author":"T Ma","year":"2004","unstructured":"Ma T, Miyanishi K, Suen A, Epstein NJ, Tomita T, Smith RL et al (2004) Human interleukin-1-induced murine osteoclastogenesis is dependent on RANKL, but independent of TNF-\u03b1. Cytokine 26(3):138\u2013144","journal-title":"Cytokine"},{"issue":"1","key":"10769_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar4127","volume":"15","author":"J-Y Choe","year":"2013","unstructured":"Choe J-Y, Park K-Y, Park S-H, Lee S-I, Kim S-K (2013) Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6\/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes. Arthritis Res Therapy 15(1):1\u201312","journal-title":"Arthritis Res Therapy"},{"key":"10769_CR34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00011-014-0717-5","volume":"63","author":"S Saravanan","year":"2014","unstructured":"Saravanan S, Hairul Islam V, Thirugnanasambantham K, Pazhanivel N, Raghuraman N, Gabriel Paulraj M et al (2014) Swertiamarin ameliorates inflammation and osteoclastogenesis intermediates in IL-1\u03b2 induced rat fibroblast-like synoviocytes. Inflamm Res 63:451\u2013462","journal-title":"Inflamm Res"},{"key":"10769_CR35","doi-asserted-by":"crossref","unstructured":"Jung SM, Kim KW, Yang C-W, Park S-H, Ju JH (2014) Cytokine-mediated bone destruction in rheumatoid arthritis. J Immunol Res.;2014","DOI":"10.1155\/2014\/263625"},{"key":"10769_CR36","doi-asserted-by":"crossref","unstructured":"Tanaka S (2019) RANKL is a therapeutic target of bone destruction in rheumatoid arthritis. F1000 Research. 8","DOI":"10.12688\/f1000research.17296.1"},{"key":"10769_CR37","first-page":"1","volume":"14","author":"JY Kim","year":"2012","unstructured":"Kim JY, Lee EY, Lee EB, Lee YJ, Yoo HJ, Choi J et al (2012) Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis. Arthritis Res Therapy 14:1\u20139","journal-title":"Arthritis Res Therapy"},{"key":"10769_CR38","doi-asserted-by":"crossref","unstructured":"Kumar R, Baker KM, Pan J (2010) Activation of the renin-angiotensin system in heart failure. heart failure: A companion to braunwald\u2019s heart disease. 134\u2013151","DOI":"10.1016\/B978-1-4160-5895-3.10009-9"},{"issue":"2","key":"10769_CR39","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI200523394","volume":"115","author":"S Wei","year":"2005","unstructured":"Wei S, Kitaura H, Zhou P, Ross FP, Teitelbaum SL (2005) IL-1 mediates TNF-induced osteoclastogenesis. J Clin Investig 115(2):282\u2013290","journal-title":"J Clin Investig"},{"issue":"1","key":"10769_CR40","doi-asserted-by":"crossref","first-page":"41411","DOI":"10.1038\/srep41411","volume":"7","author":"W Feng","year":"2017","unstructured":"Feng W, Liu H, Luo T, Liu D, Du J, Sun J et al (2017) Combination of IL-6 and sIL-6R differentially regulate varying levels of RANKL-induced osteoclastogenesis through NF-\u03baB, ERK and JNK signaling pathways. Sci Rep 7(1):41411","journal-title":"Sci Rep"},{"issue":"4","key":"10769_CR41","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/art.33446","volume":"64","author":"KW Kim","year":"2012","unstructured":"Kim KW, Kim HR, Park JY, Park JS, Oh HJ, Woo YJ et al (2012) Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts. Arthr Rhuem 64(4):1015\u20131023","journal-title":"Arthr Rhuem"},{"issue":"2","key":"10769_CR42","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/ard.2010.132233","volume":"70","author":"A Hot","year":"2011","unstructured":"Hot A, Zrioual S, Toh M-L, Lenief V, Miossec P (2011) IL-17A-versus IL-17F-induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in rheumatoid synoviocytes. Ann Rheum Dis 70(2):341\u2013348","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10769_CR43","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.imlet.2009.10.012","volume":"127","author":"X Li","year":"2010","unstructured":"Li X, Kim K-W, Cho M-L, Ju J-H, Kang C-M, Oh H-J et al (2010) IL-23 induces receptor activator of NF-\u03baB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-\u03baB signal pathways. Immunol Lett 127(2):100\u2013107","journal-title":"Immunol Lett"},{"key":"10769_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-018-1791-9","volume":"21","author":"K-A Lee","year":"2019","unstructured":"Lee K-A, Kim K-W, Kim B-M, Won J-Y, Min HK, Lee DW et al (2019) Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis. Arthritis Res Therapy 21:1\u201313","journal-title":"Arthritis Res Therapy"},{"issue":"4","key":"10769_CR45","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/eji.202048681","volume":"51","author":"S Umar","year":"2021","unstructured":"Umar S, Palasiewicz K, Van Raemdonck K, Volin MV, Romay B, Ahmad I et al (2021) CCL25 and CCR9 is a unique pathway that potentiates Pannus formation by remodeling RA macrophages into mature osteoclasts. Eur J Immunol 51(4):903\u2013914","journal-title":"Eur J Immunol"},{"issue":"1","key":"10769_CR46","first-page":"1","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun S-C (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Therapy 2(1):1\u20139","journal-title":"Signal Transduct Target Therapy"},{"key":"10769_CR47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cyto.2018.03.005","volume":"106","author":"P Dinesh","year":"2018","unstructured":"Dinesh P, Rasool M (2018) Berberine inhibits IL-21\/IL-21R mediated inflammatory proliferation of fibroblast-like synoviocytes through the Attenuation of PI3K\/Akt signaling pathway and ameliorates IL-21 mediated osteoclastogenesis. Cytokine 106:54\u201366","journal-title":"Cytokine"},{"issue":"12","key":"10769_CR48","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","volume":"106","author":"J Lam","year":"2000","unstructured":"Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL (2000) TNF-\u03b1 induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Investig 106(12):1481\u20131488","journal-title":"J Clin Investig"},{"issue":"3","key":"10769_CR49","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.4049\/jimmunol.0803007","volume":"183","author":"JH Kim","year":"2009","unstructured":"Kim JH, Jin HM, Kim K, Song I, Youn BU, Matsuo K et al (2009) The mechanism of osteoclast differentiation induced by IL-1. J Immunol 183(3):1862\u20131870","journal-title":"J Immunol"},{"issue":"2","key":"10769_CR50","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1089\/jmf.2018.4259","volume":"22","author":"H-R Kim","year":"2019","unstructured":"Kim H-R, Kim B-M, Won J-Y, Lee K-A, Ko HM, Kang YS et al (2019) Quercetin, a plant polyphenol, has potential for the prevention of bone destruction in rheumatoid arthritis. J Med Food 22(2):152\u2013161","journal-title":"J Med Food"},{"issue":"1","key":"10769_CR51","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","volume":"8","author":"C Xue","year":"2023","unstructured":"Xue C, Yao Q, Gu X, Shi Q, Yuan X, Chu Q et al (2023) Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. Signal Transduct Target Therapy 8(1):204","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"10769_CR52","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W (2021) The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Therapy 6(1):402","journal-title":"Signal Transduct Target Therapy"},{"issue":"11","key":"10769_CR53","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/rheumatology\/ken363","volume":"47","author":"M Hashizume","year":"2008","unstructured":"Hashizume M, Hayakawa N, Mihara M (2008) IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-\u03b1 and IL-17. Rheumatology 47(11):1635\u20131640","journal-title":"Rheumatology"},{"issue":"1","key":"10769_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-015-0532-6","volume":"17","author":"H Tsushima","year":"2015","unstructured":"Tsushima H, Okazaki K, Ishihara K, Ushijima T, Iwamoto Y (2015) CCAAT\/enhancer-binding protein \u03b2 promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis. Arthritis Res Therapy 17(1):1\u201311","journal-title":"Arthritis Res Therapy"},{"issue":"2","key":"10769_CR55","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1002\/jcb.27502","volume":"120","author":"R Ganesan","year":"2019","unstructured":"Ganesan R, Rasool M (2019) Ferulic acid inhibits Interleukin 17-dependent expression of nodal pathogenic mediators in fibroblast\u2010like synoviocytes of rheumatoid arthritis. J Cell Biochem 120(2):1878\u20131893","journal-title":"J Cell Biochem"},{"key":"10769_CR56","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.molimm.2017.09.003","volume":"91","author":"R Ganesan","year":"2017","unstructured":"Ganesan R, Rasool M (2017) Interleukin 17 regulates SHP-2 and IL-17RA\/STAT-3 dependent Cyr61, IL-23 and GM-CSF expression and RANKL mediated osteoclastogenesis by fibroblast-like synoviocytes in rheumatoid arthritis. Mol Immunol 91:134\u2013144","journal-title":"Mol Immunol"},{"issue":"1","key":"10769_CR57","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo AS, Lam HY, Yap KC, Jacot W, Jones RH et al (2023) PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer 22(1):138","journal-title":"Mol Cancer"},{"issue":"9","key":"10769_CR58","doi-asserted-by":"crossref","first-page":"a011189","DOI":"10.1101\/cshperspect.a011189","volume":"4","author":"BA Hemmings","year":"2012","unstructured":"Hemmings BA, Restuccia DF (2012) Pi3k-pkb\/akt pathway. Cold Spring Harb Perspect Biol 4(9):a011189","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"10769_CR59","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41392-023-01331-9","volume":"8","author":"Q Ding","year":"2023","unstructured":"Ding Q, Hu W, Wang R, Yang Q, Zhu M, Li M et al (2023) Signaling pathways in rheumatoid arthritis: implications for targeted therapy. Signal Transduct Target Therapy 8(1):68","journal-title":"Signal Transduct Target Therapy"},{"issue":"3","key":"10769_CR60","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/art.33390","volume":"64","author":"SK Kwok","year":"2012","unstructured":"Kwok SK, Cho ML, Park MK, Oh HJ, Park JS, Her YM et al (2012) Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen\u2010induced arthritis. Arthr Rhuem 64(3):740\u2013751","journal-title":"Arthr Rhuem"},{"issue":"7","key":"10769_CR61","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1039\/C5MB00101C","volume":"11","author":"T Ersahin","year":"2015","unstructured":"Ersahin T, Tuncbag N, Cetin-Atalay R (2015) The PI3K\/AKT\/mTOR interactive pathway. Mol Biosyst 11(7):1946\u20131954","journal-title":"Mol Biosyst"},{"key":"10769_CR62","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10753-012-9524-8","volume":"36","author":"W Zhang","year":"2013","unstructured":"Zhang W, Cong X-L, Qin Y-H, He Z-W, He D-Y, Dai S-M (2013) IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis. Inflammation 36:103\u2013109","journal-title":"Inflammation"},{"key":"10769_CR63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cyto.2015.10.005","volume":"77","author":"E-J Lee","year":"2016","unstructured":"Lee E-J, So MW, Hong S, Kim Y-G, Yoo B, Lee C-K (2016) Interleukin-33 acts as a transcriptional repressor and extracellular cytokine in fibroblast-like synoviocytes in patients with rheumatoid arthritis. Cytokine 77:35\u201343","journal-title":"Cytokine"},{"issue":"2","key":"10769_CR64","first-page":"1","volume":"13","author":"H-R Kim","year":"2011","unstructured":"Kim H-R, Kim K-W, Jung HG, Yoon K-S, Oh H-J, Cho M-L et al (2011) Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis. Arthritis Res Therapy 13(2):1\u201313","journal-title":"Arthritis Res Therapy"},{"issue":"9","key":"10769_CR65","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1101\/gad.5.9.1538","volume":"5","author":"Z Cao","year":"1991","unstructured":"Cao Z, Umek RM, McKnight SL (1991) Regulated expression of three C\/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5(9):1538\u20131552","journal-title":"Genes Dev"},{"key":"10769_CR66","doi-asserted-by":"crossref","first-page":"113687","DOI":"10.1016\/j.biopha.2022.113687","volume":"155","author":"X Cai","year":"2022","unstructured":"Cai X, Zheng Y, Ren F, Zhang S, Wu L, Yao Y (2022) Secretory phosphoprotein 1 secreted by fibroblast-like synoviocytes promotes osteoclasts formation via PI3K\/AKT signaling in collagen-induced arthritis. Biomed Pharmacother 155:113687","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10769_CR67","doi-asserted-by":"crossref","first-page":"113490","DOI":"10.1016\/j.yexcr.2023.113490","volume":"424","author":"X Hu","year":"2023","unstructured":"Hu X, Li M, Zhang Y, Sang K, Zhang Y, Li W et al (2023) An innovative immunotherapeutic strategy for rheumatoid arthritis: selectively suppressing angiogenesis and osteoclast differentiation by fully human antibody targeting thymocyte antigen-1. Exp Cell Res 424(1):113490","journal-title":"Exp Cell Res"},{"issue":"3","key":"10769_CR68","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ajpath.2013.05.027","volume":"183","author":"J-S Park","year":"2013","unstructured":"Park J-S, Kwok S-K, Lim M-A, Oh H-J, Kim E-K, Jhun J-Y et al (2013) TWEAK promotes osteoclastogenesis in rheumatoid arthritis. Am J Pathol 183(3):857\u2013867","journal-title":"Am J Pathol"},{"issue":"5","key":"10769_CR69","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3109\/03009742.2012.670263","volume":"41","author":"L Fan","year":"2012","unstructured":"Fan L, He D, Wang Q, Zong M, Zhang H, Yang L et al (2012) Citrullinated vimentin stimulates proliferation, pro-inflammatory cytokine secretion, and PADI4 and RANKL expression of fibroblast-like synoviocytes in rheumatoid arthritis. Scand J Rheumatol 41(5):354\u2013358","journal-title":"Scand J Rheumatol"},{"key":"10769_CR70","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bjid.2015.10.011","volume":"20","author":"S Mukherjee","year":"2016","unstructured":"Mukherjee S, Karmakar S, Babu SPS (2016) TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review. Brazilian J Infect Dis 20:193\u2013204","journal-title":"Brazilian J Infect Dis"},{"key":"10769_CR71","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.intimp.2018.03.002","volume":"59","author":"K Vijay","year":"2018","unstructured":"Vijay K (2018) Toll-like receptors in immunity and inflammatory diseases: past, present, and future. Int Immunopharmacol 59:391\u2013412","journal-title":"Int Immunopharmacol"},{"key":"10769_CR72","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12016-019-08742-z","volume":"58","author":"MI Arleevskaya","year":"2020","unstructured":"Arleevskaya MI, Larionova R, Brooks WH, Bettacchioli E, Renaudineau Y (2020) Toll-like receptors, infections, and rheumatoid arthritis. Clin Rev Allergy Immunol 58:172\u2013181","journal-title":"Clin Rev Allergy Immunol"},{"key":"10769_CR73","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cyto.2016.06.024","volume":"85","author":"V Sugitharini","year":"2016","unstructured":"Sugitharini V, Shahana P, Prema A, Thangam EB (2016) TLR2 and TLR4 co-activation utilizes distinct signaling pathways for the production of Th1\/Th2\/Th17 cytokines in neonatal immune cells. Cytokine 85:191\u2013200","journal-title":"Cytokine"},{"issue":"3","key":"10769_CR74","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/jb\/mvz033","volume":"166","author":"K-W Kim","year":"2019","unstructured":"Kim K-W, Kim B-M, Won J-Y, Lee K-A, Kim H-R, Lee S-H (2019) Toll-like receptor 7 regulates osteoclastogenesis in rheumatoid arthritis. J Biochem 166(3):259\u2013270","journal-title":"J Biochem"},{"issue":"1","key":"10769_CR75","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.imlet.2009.02.006","volume":"124","author":"K-W Kim","year":"2009","unstructured":"Kim K-W, Cho M-L, Oh H-J, Kim H-R, Kang C-M, Heo Y-M et al (2009) TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis. Immunol Lett 124(1):9\u201317","journal-title":"Immunol Lett"},{"issue":"8","key":"10769_CR76","first-page":"609","volume":"22","author":"C Yujuan","year":"2021","unstructured":"Yujuan C, Junhong L, Yao Z, Xianping M, Huashan Y (2021) Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses. J Zhejiang Univ Sci B 22(8):609","journal-title":"J Zhejiang Univ Sci B"},{"issue":"1","key":"10769_CR77","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cytogfr.2008.11.007","volume":"20","author":"J Xu","year":"2009","unstructured":"Xu J, Wu HF, Ang ES, Yip K, Woloszyn M, Zheng MH et al (2009) NF-\u03baB modulators in osteolytic bone diseases. Cytokine Growth Factor Rev 20(1):7\u201317","journal-title":"Cytokine Growth Factor Rev"},{"issue":"8","key":"10769_CR78","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1002\/jcp.26517","volume":"233","author":"M Liu","year":"2018","unstructured":"Liu M, Zhou X, Zhou L, Liu Z, Yuan J, Cheng J et al (2018) Carnosic acid inhibits inflammation response and joint destruction on osteoclasts, fibroblast-like synoviocytes, and collagen\u2010induced arthritis rats. J Cell Physiol 233(8):6291\u20136303","journal-title":"J Cell Physiol"},{"issue":"1","key":"10769_CR79","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","volume":"12","author":"T Wada","year":"2006","unstructured":"Wada T, Nakashima T, Hiroshi N, Penninger JM (2006) RANKL\u2013RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 12(1):17\u201325","journal-title":"Trends Mol Med"},{"issue":"1","key":"10769_CR80","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bone.2013.02.005","volume":"55","author":"HD Jang","year":"2013","unstructured":"Jang HD, Noh JY, Shin JH, Lin JJ, Lee SY (2013) PTEN regulation by the Akt\/GSK-3\u03b2 axis during RANKL signaling. Bone 55(1):126\u2013131","journal-title":"Bone"},{"key":"10769_CR81","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00774-020-01162-6","volume":"39","author":"N Udagawa","year":"2021","unstructured":"Udagawa N, Koide M, Nakamura M, Nakamichi Y, Yamashita T, Uehara S et al (2021) Osteoclast differentiation by RANKL and OPG signaling pathways. J Bone Miner Metab 39:19\u201326","journal-title":"J Bone Miner Metab"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10769-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10769-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10769-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T04:24:58Z","timestamp":1766895898000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10769-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10769"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10769-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"662"}}